Cytokinetics, Inc. (NASDAQ: CYTK) is engaged as a late-stage biopharmaceutical company, which is focused on the research, development, and commercialization ...
Enochian Biosciences, Inc. (NASDAQ: ENOB) is engaged as a biopharmaceutical company, which is focused on the research, development, manufacturing, and ...
Not all analysts and their respective opinions are created equal. Reputation and track record can be defining features that elevate ...
This year has been one for the record books. A prolific pandemic, crippling economic downturn, civil unrest, and one of ...
In a sign of shifting perceptions, the European market appears more amenable to the idea of special purpose acquisition companies, ...
Despite the lingering coronavirus pandemic, U.S. stocks continue their march higher. Russia’s vaccine development announcement helped push major indices to ...
The global pandemic continues to sap money from the economy at an alarming rate. While the stock market continues to ...
Baron Group, founded by fund manager Ron Baron, recently made a number of changes to its holdings in the fourth ...
Seth Klarman, a value investor and hedge fund manager of Baupost Group, acquired a significant stake in Vista Oil & ...
In a recent report issued through Bloomberg, dominant U.S. bank, JP Morgan Chase & Co. (NYSE: JPM) believes that their ...
